Medical Aesthetics Market - Distribution by Type of Product and / or Device Offered, Type of Procedure, End User, Gender, Distribution Channel, and Key Geographical Regions : Industry Trends and Global Forecasts

Description

The medical aesthetics market is valued at USD 35 billion in 2023 growing at a CAGR of 9.3% during the forecast period 2023-2035.

The growing demand for medical aesthetic solutions in recent years can be attributed to various factors, including the desire to maintain a youthful appearance, the influence of social media, technological advancements, celebrity endorsements, and the support of beauticians and medical professionals. The COVID pandemic has also contributed significantly towards the increased number of annual aesthetic treatments. Medical aesthetics is a well-established branch of modern medicine that primarily focuses on enhancing the cosmetic appearance of an individual without clinical surgery. These treatments are mainly used for anti-aging purposes by reducing fine lines and wrinkles, lifting flabby skin, and skin rejuvenation. Medical aesthetic procedures can also help in reducing excess fat and cellulite, unwanted hair, and spider veins. According to a study conducted by the International Society of Aesthetic Plastic Surgery (ISAPS), over 15 million invasive aesthetic procedures and 19 million non-invasive aesthetic procedures have been performed globally in 2022. It is worth mentioning that nearly 90% of the industry clientele are women, however, these aesthetic procedures are also gaining popularity among men. In fact, men have shown an increased interest in the majority of major surgical and nonsurgical procedures, with the top cosmetic surgical procedures for men being rhinoplasty, eyelid surgery, cheek implant, breast reduction, liposuction, tummy tuck, and ear surgery. The reasons behind the growth of the male aesthetic market tend to be the same as those that have led to the growth of the female aesthetic market, including the desire for natural-looking results, minimally invasive procedures, and increased awareness of appearance.

Due to the high demand for these procedures, medical aesthetics companies have developed medical aesthetics products & devices. The main focus of medical aesthetics companies is to develop non-surgical or minimally invasive solutions. The majority of these treatments don't require a full surgical procedure. This means less pain and discomfort, fewer risks, shorter hospital stays, and long-lasting results. Some of the most common minimally invasive treatments are Botulism toxins and aesthetic filler. These treatments are mainly used for improving glabellar lines and tightening the skin. However, the advantages of aesthetic treatments aren't only cosmetic. They also help in solving other common healthcare problems. Botulism toxin is used to control sweating and migraines. Body contouring devices, laser hair removal, tattoo removal, and nail treatments are some of the other common non-surgical treatments. Body contouring devices are used for tightening the skin, reducing fat, and reducing cellulite.

Medical aesthetics treatments can be performed at a medical aesthetic clinic or at a medical spa. Dermatologists, plastic surgeons, doctors, nurse practitioners, registered nurses and aestheticians are among the medical professionals who can provide medical aesthetics treatments. It is interesting to note that more than 70% of the present medical aesthetics market is managed by hospitals, clinics and medical spas. In addition, South Korea, the plastic surgery capital in the world, is the country with the highest cosmetic surgeries per capita. This is because of the well-established cosmetic surgery infrastructure and the skilled medical professionals who encourage aesthetics medical tourism to South Korea. The main concern is that some medical professionals and the medical aesthetics companies are violating the regulatory guidelines, which can lead to side-effects. Therefore, it is extremely important for the patient to undergo medical aesthetics treatment by a licensed medical professional, using certified aesthetic devices, to avoid any such risks and complications. By overcoming these obstacles and meeting the increasing demand for medical aesthetics services, medical aesthetics companies are projected to see tremendous growth in the coming years.

Key Market Segments

Type of Product and / or Device Offered

Botulinum Toxin
Dermal Fillers
Chemical Peels
Body Contouring
Gluteal Implants
Hair Removal
Breast Implants
Other Products / Devices

Type of Procedure

Non Invasive
Minimally Invasive
Invasive

End User

Hospitals
Clincs / Med Spas and Dermatology / Cosmetology Centers
Other end users

Gender

Male
Female

Distribution Channel

Direct Distribution
Indirect Distribution

Key Geographical Regions

North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America

Research Coverage:

The report studies the medical aesthetics market based on type of product and / or device offered, type of procedure, end user, gender, distribution channel, and key geographical regions

The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.

The report forecasts the revenue of market segments with respect to five major regions

The report provides an overview of medical aesthetics, including its evolution, types, and application areas. It also covers the benefits of these procedures compared to traditional beauty treatments and the side effects associated with them. The chapter also covers the key drivers of growth, new technologies, key issues and future prospects in this field.

Comprehensive analysis of the current landscape of medical aesthetics developers considering parameters such as establishment year, company size, headquarters, type of offering (product and / or device), type of products and / or devices offered, application area, type of procedure and end user

In-depth profiles of companies offering medical aesthetic procedures products and / or devices, focusing on company overviews, financial information (where available), offered medical aesthetic procedures, recent advancements, and informed future prospects.

Detailed company competitiveness evaluation of medical aesthetics company, considering supplier strength in terms of type of offering, type of product and / or device offered and type of procedure, and number of end users served.

An analysis of partnerships established in this sector since 2018, covering merger and acquisition, distribution, commercialization, licensing, supply, product development, product and technology integration and manufacturing agreements.

A comprehensive examination of funding and investments made in medical aesthetics companies since 2018, encompassing venture capital financing, secondary offerings, private placements, grants, debt financing, and other equity.

The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.

Key Benefits of Buying this Report

The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.

Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.

The report provides stakeholders with a pulse on the medical aesthetics market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

ADSS
Allergan Aesthetics
Astiland, Beijing Kes Biological Technology
BTL Aesthetics
Candela Medical
Classys
Croma Pharma
Cynosure
Daeyang Medical
Establishment Labs
Galderma
Guangzhou Itech Aesthetics

IBSA
Lumenis
Lutronic
MedicalZone
Mentor
Sanhe Medical
Shanghai Haohai Biological Technology
Sinclair Pharma
Sincoheren
Skin Tech Pharma
Wontech
Zesay Beauty

Product Code: RA100467

1. PREFACE

1.1. Introduction
1.2. Project Objectives
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
- 2.7.1. Demographics
- 2.7.2. Economic Factors
- 2.7.3. Government Regulations
- 2.7.4. Supply Chain
- 2.7.5. COVID Impact / Related Factors
- 2.7.6. Market Access
- 2.7.7. Healthcare Policies
- 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

3.1. Chapter Overview
3.2. Market Dynamics
- 3.2.1. Time Period
  - 3.2.1.1. Historical Trends
  - 3.2.1.2. Current and Forecasted Estimates
- 3.2.2. Currency Coverage
  - 3.2.2.1. Overview of Major Currencies Affecting the Market
  - 3.2.2.2. Impact of Currency Fluctuations on the Industry
- 3.2.3. Foreign Exchange Impact
  - 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
  - 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
- 3.2.4. Recession
  - 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
  - 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
- 3.2.5. Inflation
  - 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
  - 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

5.1. Chapter Overview
5.2. Concept of Medical Aesthetics
5.3. Evolution of Medical Aesthetics
5.4. Types of Medical Aesthetic Procedures
- 5.4.1. Non-invasive Procedures
  - 5.4.1.1. Facial Aesthetics
    - 5.4.1.1.1. Botulinum Toxin
    - 5.4.1.1.2. Dermal Fillers
    - 5.4.1.1.3. Chemical Peels
    - 5.4.1.1.4. Microdermabrasion
    - 5.4.1.1.5. Microneedling
    - 5.4.1.1.6. Thread Lift
  - 5.4.1.2. Body Contouring
  - 5.4.1.3. Hair Removal
    - 5.4.1.3.1. Intense Pulse Light Hair Removal
    - 5.4.1.3.2. Laser Hair Removal
  - 5.4.1.4. Tattoo Removal
  - 5.4.1.5. Nail Treatment
  - 5.4.1.6. Eyelash Treatment
  - 5.4.1.7. Permanent Make-up
- 5.4.2. Invasive Procedures
  - 5.4.2.1. Breast Surgery
  - 5.4.2.2. Gluteal Implants
  - 5.4.2.3. Facial Surgery
  - 5.4.2.4. Liposuction
  - 5.4.2.5. Cosmetic Gynecology
5.5. Advantages of Medical Aesthetics
5.6. Side Effects of Medical Aesthetics
5.7. Key Growth Drivers
5.8. Emerging Technologies in Medical Aesthetics
- 5.8.1. Virtual Reality in Medical Aesthetics
- 5.8.2. Augmented Reality in Medical Aesthetics
- 5.8.3. Artificial Intelligence in Medical Aesthetics
- 5.8.4. Telemedicine in Medical Aesthetics
5.9. Key Challenges of Medical Aesthetics
5.10. Future Perspectives

6. MARKET LANDSCAPE

6.1. Chapter Overview
6.2. Medical Aesthetic Companies: Overall Market Landscape
- 6.2.1. Analysis by Year of Establishment
- 6.2.2. Analysis by Company Size
- 6.2.3. Analysis by Location of Headquarters (Region)
- 6.2.4. Analysis by Location of Headquarters (Country)
- 6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
- 6.2.6. Analysis by Company Size and Location of Headquarters (Region)
- 6.2.7. Analysis by Type of Offering
- 6.2.8. Analysis by Type of Products and / or Devices Offered
- 6.2.9. Analysis by Type of Facial Aesthetic Products and / or Devices Offered
- 6.2.10. Analysis by Type of Body Contouring Products and / or Devices Offered
- 6.2.11. Analysis by Type of Hair Removal Devices Offered
- 6.2.12. Analysis by Type of Breast Aesthetic Products and / or Devices Offered
- 6.2.13. Analysis by Application Area
- 6.2.14. Analysis by Type of Procedure
- 6.2.15. Analysis by End-user
- 6.2.16. Analysis by Type of Products and / or Devices Offered and Location of Headquarters (Region)
- 6.2.17. Analysis by Type of Procedure and Location of Headquarters (Region)

7. COMPANY PROFILES

7.1. Chapter Overview
7.2. Detailed Company Profiles of Key Players
- 7.2.1. Companies Headquartered in North America
  - 7.2.1.1. Allergan Aesthetics
    - 7.2.1.1.1. Company Overview
    - 7.2.1.1.2. Financial Information
    - 7.2.1.1.3. Medical Aesthetics Portfolio
    - 7.2.1.1.4. Recent Developments and Future Outlook
  - 7.2.1.2. Candela Medical
    - 7.2.1.2.1. Company Overview
    - 7.2.1.2.2. Medical Aesthetics Portfolio
    - 7.2.1.2.3. Recent Developments and Future Outlook
  - 7.2.1.3. Cynosure
    - 7.2.1.3.1. Company Overview
    - 7.2.1.3.2. Medical Aesthetics Portfolio
    - 7.2.1.3.3. Recent Developments and Future Outlook
  - 7.2.1.4. Lutronic
    - 7.2.1.4.1. Company Overview
    - 7.2.1.4.2. Medical Aesthetics Portfolio
    - 7.2.1.4.3. Recent Developments and Future Outlook
  - 7.2.1.5. Mentor
    - 7.2.1.5.1. Company Overview
    - 7.2.1.5.2. Medical Aesthetics Portfolio
    - 7.2.1.5.3. Recent Developments and Future Outlook
- 7.2.2. Companies Headquartered in Europe
  - 7.2.2.1. BTL Aesthetics
    - 7.2.2.1.1. Company Overview
    - 7.2.2.1.2. Medical Aesthetics Portfolio
    - 7.2.2.1.3. Recent Developments and Future Outlook
  - 7.2.2.2. Croma Pharma
    - 7.2.2.2.1. Company Overview
    - 7.2.2.2.2. Financial Information
    - 7.2.2.2.3. Medical Aesthetics Portfolio
    - 7.2.2.2.4. Recent Developments and Future Outlook
  - 7.2.2.3. Galderma
    - 7.2.2.3.1. Company Overview
    - 7.2.2.3.2. Financial Information
    - 7.2.2.3.3. Medical Aesthetics Portfolio
    - 7.2.2.3.4. Recent Developments and Future Outlook
  - 7.2.2.4. IBSA
    - 7.2.2.4.1. Company Overview
    - 7.2.2.4.2. Medical Aesthetics Portfolio
    - 7.2.2.4.3. Recent Developments and Future Outlook
  - 7.2.2.5. Sinclair Pharma
    - 7.2.2.5.1. Company Overview
    - 7.2.2.5.2. Medical Aesthetics Portfolio
    - 7.2.2.5.3. Recent Developments and Future Outlook
- 7.2.3. Companies Headquartered in Asia-Pacific and Rest of the World
  - 7.2.3.1. Classys
    - 7.2.3.1.1. Company Overview
    - 7.2.3.1.2. Financial Information
    - 7.2.3.1.3. Medical Aesthetics Portfolio
    - 7.2.3.1.4. Recent Developments and Future Outlook
  - 7.2.3.2. Daeyang Medical
    - 7.2.3.2.1. Company Overview
    - 7.2.3.2.2. Medical Aesthetics Portfolio
    - 7.2.3.2.3. Recent Developments and Future Outlook
  - 7.2.3.3. Establishment Labs
    - 7.2.3.3.1. Company Overview
    - 7.2.3.3.2. Financial Information
    - 7.2.3.3.3. Medical Aesthetics Portfolio
    - 7.2.3.3.4. Recent Developments and Future Outlook
  - 7.2.3.4. Lumenis
    - 7.2.3.4.1. Company Overview
    - 7.2.3.4.2. Medical Aesthetics Portfolio
    - 7.2.3.4.3. Recent Developments and Future Outlook
  - 7.2.3.5. Shanghai Haohai Biological Technology
    - 7.2.3.5.1. Company Overview
    - 7.2.3.5.2. Financial Information
    - 7.2.3.5.3. Medical Aesthetics Portfolio
    - 7.2.3.5.4. Recent Developments and Future Outlook
7.3. Short Profiles of Other Prominent Players
- 7.3.1. ADSS
  - 7.3.1.1. Company Overview
  - 7.3.1.2. Medical Aesthetics Portfolio
- 7.3.2. Astiland
  - 7.3.2.1. Company Overview
  - 7.3.2.2. Medical Aesthetics Portfolio
- 7.3.3. Beijing Kes Biological Technology
  - 7.3.3.1. Company Overview
  - 7.3.3.2. Medical Aesthetics Portfolio
- 7.3.4. Guangzhou Itech Aesthetics 7.3.4.1.Company Overview
  - 7.3.4.2. Medical Aesthetics Portfolio
- 7.3.5. MedicalZone
  - 7.3.5.1. Company Overview
  - 7.3.5.2. Medical Aesthetics Portfolio
- 7.3.6. Sanhe Medical
  - 7.3.6.1. Company Overview
  - 7.3.6.2. Medical Aesthetics Portfolio
- 7.3.7. Sincoheren
  - 7.3.7.1. Company Overview
  - 7.3.7.2. Medical Aesthetics Portfolio
- 7.3.8. Skin Tech Pharma
  - 7.3.8.1. Company Overview
  - 7.3.8.2. Medical Aesthetics Portfolio
- 7.3.9. Wontech
  - 7.3.9.1. Company Overview
  - 7.3.9.2. Medical Aesthetics Portfolio
- 7.3.10. Zesay Beauty
  - 7.3.10.1. Company Overview
  - 7.3.10.2. Medical Aesthetics Portfolio

8. COMPANY COMPETITIVENESS ANALYSIS

8.1. Chapter Overview
8.2. Key Assumptions and Parameters
8.3. Methodology
8.4. Medical Aesthetics: Company Competitiveness Analysis
- 8.4.1. Companies based in North America
- 8.4.2. Companies based in Europe
- 8.4.3 Companies based in Asia-Pacific and Rest of the World

9. PARTNERSHIPS AND COLLABORATIONS

9.1. Chapter Overview
9.2. Partnership Models
9.3. Medical Aesthetics: Partnerships and Collaborations
- 9.3.1. Analysis by Year of Partnership
- 9.3.2. Analysis by Type of Partnership
- 9.3.3. Analysis by Year and Type of Partnership
- 9.3.4. Analysis by Focus Area
- 9.3.5. Most Active Players: Analysis by Number of Partnerships
9.4. Analysis by Geography
- 9.4.1. Local and International Agreements
- 9.4.2. Intracontinental and Intercontinental Agreements

10. FUNDING AND INVESTMENTS

10.1. Chapter Overview
10.2. Funding Models
10.3. Medical Aesthetics: Funding and Investments
- 10.3.1. Analysis by Year of Funding
- 10.3.2. Analysis by Amount Invested
- 10.3.3. Analysis by Type of Funding
- 10.3.4. Analysis by Year and Type of Funding
- 10.3.5. Analysis by Type of Funding and Amount Invested
- 10.3.6. Analysis by Geography
- 10.3.7. Most Active Players
  - 10.3.7.1. Analysis by Number of Funding Instances
  - 10.3.7.2. Analysis by Amount Raised
- 10.3.8. Leading Investors: Analysis by Number of Funding Instances
- 10.3.9. Analysis by Company Size and Amount Invested
10.4. Concluding Remarks

11. DELT ANALYSIS

11.1. Chapter Overview
11.2. Methodology
11.3. Key Parameters
- 11.3.1. Demographical Factors
- 11.3.2. Environmental Factors
- 11.3.3. Legal Factors
- 11.3.4. Technological Factors
11.4. Medical Aesthetics: DELT Analysis
- 11.4.1. Allergan Aesthetics
- 11.4.2. Candela
- 11.4.3. Cutera
- 11.4.4. Biotechitalia
- 11.4.5. Sinclair Pharma
- 11.4.6. Merz Pharma
- 11.4.7. Dermosistemi
- 11.4.8. Alma Lasers
- 11.4.9. Bison Medical
11.5. Conclusion

12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

12.1. Chapter Overview
12.2. Market Drivers
12.3. Market Restraints
12.4. Market Opportunities
12.5. Market Challenges
12.6. Conclusion

13. GLOBAL MEDICAL AESTHETICS MARKET

13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Global Medical Aesthetics Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 13.3.1. Scenario Analysis
  - 13.3.1.1. Conservative Scenario Analysis
  - 13.3.1.2. Optimistic Scenario Analysis
13.4. Key Market Segmentations
13.5. Dynamic Dashboards

14. MEDICAL AESTHETICS MARKET, BY TYPE OF PRODUCT AND / OR DEVICE OFFERED

14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Medical Aesthetics Market: Distribution by Type of Product and / or Device Offered, 2018, 2023 and 2035
- 14.3.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 14.3.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 14.3.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 14.3.4. Body Contouring: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 14.3.5. Hair Removal: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 14.3.6. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 14.3.7. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 14.3.8. Other Products and / or Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.4. Data Triangulation and Validation

15. MEDICAL AESTHETICS MARKET, BY TYPE OF PROCEDURE

15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Medical Aesthetics Market: Distribution by Type of Procedure, 2018, 2023 and 2035
- 15.3.1. Non-invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 15.3.2. Minimally Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 15.3.3. Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.4. Data Triangulation and Validation

16. MEDICAL AESTHETICS MARKET, BY END-USER

16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Medical Aesthetics Market: Distribution by End-user, 2018, 2023 and 2035
- 16.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

16.3.2.. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

16.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

16.4. Data Triangulation and Validation

17. MEDICAL AESTHETICS MARKET, BY GENDER

17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Medical Aesthetics Market: Distribution by Gender, 2018, 2023 and 2035
- 17.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 17.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4. Data Triangulation and Validation

18. MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL

18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Medical Aesthetics Market, by Distribution Channel, 2018, 2023 and 2035
- 18.3.1. Direct Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 18.3.2. Indirect Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.4. Data Triangulation and Validation

19. MEDICAL AESTEHTICS MARKET, BY KEY GEOGRAPHICAL REGION

19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Medical Aesthetics Market: Distribution by Key Geographical Regions, 2019, 2023 and 2035
- 19.3.1. North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.1.1. US: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.1.2. Canada: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.1.3. Mexico: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
- 19.3.2. Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.2.1. UK: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.2.2. Germany: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.2.3. France: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.2.4. Italy: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.2.5. Spain: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.2.5. Rest of the Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
- 19.3.3. Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.3.1. China: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.3.2. South Korea Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.3.3. Japan: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.3.4. India: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
- 19.3.4. Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.4.1. Turkey: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.4.2. Iran: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
- 19.3.5. Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.5.1. Brazil: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.5.2. Argentina: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  - 19.3.5.3. Rest of the Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.4. Data Triangulation and Validation

20. MEDICAL AESTHETICS PRODUCTS MARKET

20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Global Medical Aesthetics Products Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 20.3.1. Medical Aesthetics Products Market, by Type of Product Offered, 2018, 2023 and 2035
  - 20.3.1.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 20.3.1.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 20.3.1.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 20.3.1.4. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 20.3.1.5. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 20.4.1. Medical Aesthetics Products Market, by Key Geographical Regions, 2018, 2023 and 2035
  - 20.4.1.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 20.4.1.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 20.4.1.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 20.4.1.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 20.4.1.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.5. Data Triangulation and Validation